axeliaoncology.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title Home | Axelia
Description Revolutionizing Cancer About Research & Development Publications Contact Us About Research & Development Publications Contact Us Revolutionizing Cancer Therapy We aspire to crea
Keywords N/A
Server Information
WebSite axeliaoncology faviconaxeliaoncology.com
Host IP 104.196.185.20
Location United States
Related Websites
Site Rank
More to Explore
axeliaoncology.com Valuation
US$275,484
Last updated: 2023-05-18 02:43:44

axeliaoncology.com has Semrush global rank of 38,420,765. axeliaoncology.com has an estimated worth of US$ 275,484, based on its estimated Ads revenue. axeliaoncology.com receives approximately 31,787 unique visitors each day. Its web server is located in United States, with IP address 104.196.185.20. According to SiteAdvisor, axeliaoncology.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$275,484
Daily Ads Revenue US$255
Monthly Ads Revenue US$7,629
Yearly Ads Revenue US$91,546
Daily Unique Visitors 2,120
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
axeliaoncology.com. A 21600 IP: 104.196.185.20
axeliaoncology.com. NS 21600 NS Record: ns1.nameserver.net.au.
axeliaoncology.com. NS 21600 NS Record: ns3.nameserver.net.au.
axeliaoncology.com. NS 21600 NS Record: ns2.nameserver.net.au.
axeliaoncology.com. MX 3600 MX Record: 0 axeliaoncology-com.mail.protection.outlook.com.
axeliaoncology.com. TXT 3600 TXT Record: MS=ms49487644
axeliaoncology.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-18 02:43:44
About Research & Development Publications Contact Us About Research & Development Publications Contact Us Revolutionizing Cancer Therapy We aspire to create safe and effective therapies for cancer patients through the body’s own immune system. Learn More About Our Therapeutics Harnessing the Innate Immune System to Combat Checkpoint-Insensitive Tumors Our lead candidate, AXA-042, is a novel systemically-delivered TLR2/6 agonist that drives anti-tumor response through engagement of the innate immune system. Targeting a large unmet medical need in oncology Re-awakening the innate immune system in cancer patients Overcoming resistance to checkpoint blockade therapy Generation of long-lasting response in solid tumour indications Learn More About Our Lead Candidate A Highly-Experienced Leadership Team in Oncology Drug Discovery Meet The Team About Research & Development Publications Contact Us © 2023 Axelia Oncology. All Rights
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sun, 08 May 2022 08:48:35 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://axeliaoncology.com/

HTTP/2 200 
server: nginx
date: Sun, 08 May 2022 08:48:35 GMT
content-type: text/html; charset=UTF-8
content-length: 30873
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes
axeliaoncology.com Whois Information
Domain Name: AXELIAONCOLOGY.COM
Registry Domain ID: 2567446289_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.synergywholesale.com
Registrar URL: http://synergywholesale.com
Updated Date: 2022-02-07T06:16:45Z
Creation Date: 2020-10-22T05:06:08Z
Registry Expiry Date: 2023-10-22T05:06:08Z
Registrar: Synergy Wholesale Pty Ltd
Registrar IANA ID: 1609
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1.NAMESERVER.NET.AU
Name Server: NS2.NAMESERVER.NET.AU
Name Server: NS3.NAMESERVER.NET.AU
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-08T09:28:46Z <<<

Copyright © 2022 WebZZ.US 0.0287